LifeScience Cell & Gene

GC Cell and Bifarma Forge Strategic Partnership to Pioneer Cell Therapy Market in Indonesia

GC Cell, a fully integrated cell and gene therapy pioneer, is proud to announce the establishment of an MOU for strategic partnership with Bifarma, a ...

 June 20, 2024 | News

Thermo Fisher Scientific Webinar on Next-Generation T Cell AOF Formulation Medium

  Click here to register Thermo Fisher Scientific is excited to announce an upcoming webinar titled "Supporting Efficacy and Scaling with a Next-Gen...

 June 19, 2024 | News

Gilead and Kite Oncology Announce Cost-Effectiveness of Yescarta® in Large B-Cell Lymphoma in Singapore

Gilead and Kite Oncology announced new data from analyses of Yescarta® (axicabtagene ciloleucel), demonstrating its cost-effectiveness and budget impac...

 June 14, 2024 | News

Thermo Fisher Scientific Transforms Cell Therapy Production with New Automated CO2 Incubators

To support the future implementation of workflow automation in cell therapy production, Thermo Fisher Scientific introduces the Thermo Scientific™ He...

 June 13, 2024 | News

Asgard Therapeutics Selects Exothera for Clinical Manufacturing of Cancer Gene Therapy AT-108

Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it s...

 June 12, 2024 | News

Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...

 June 11, 2024 | News

Alphamab Oncology and ArriVent BioPharma Forge Strategic Collaboration to Develop Novel Antibody Drug Conjugates

Alphamab Oncology  announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. , a wholly-owned subsidiary of the Company, entered into a research an...

 June 06, 2024 | News

Annogen and Orchard Therapeutics Partner for Innovative Gene Therapy Research

 Annogen, a company with expertise in bespoke promoter design and gene expression engineering, announced a research collaboration with Orchard Therape...

 June 06, 2024 | News

HuidaGene Therapeutics and Synthego Corporation Forge Licensing Agreement for Advanced CRISPR Nuclease

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corpo...

 May 31, 2024 | News

Cytiva Launches Sefia: Advanced Platform to Transform CAR T Cell Therapy Manufacturing

Sefia cell therapy manufacturing platform comes out of Cytiva's extensive R&D expertise and in-depth understanding of CAR T manufacturing Automation...

 May 30, 2024 | News

GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis

Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...

 May 23, 2024 | News

Ractigen Therapeutics' saRNA Drug RAG-01 Receives Fast Track Designation from FDA

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been g...

 May 22, 2024 | News

Cellipont Bioservices Partners with Adva Biotechnology to Launch Innovative ADVA X3® Platform

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based...

 May 08, 2024 | News

Cytiva Innovates in Gene Therapy with Launch of ELEVECTA Cell Lines

Cytiva, a global leader in life sciences, has introduced its pioneering ELEVECTA cell lines, marking a significant advancement in...

 May 07, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close